Previous reports have demonstrated that LTF downregulation refers to a poor 5-year survival rate in breast cancer patients [36] and correlates with the biochemical recurrence in the hormone-resistant prostate cancer patients receiving radical prostatectomy [37]. Here, LTF is linked to breast carcinoma.